Ms Kimberly A Donohue, CNM | |
6701 N Charles St, Labor & Delivery, Baltimore, MD 21204-6808 | |
(443) 849-2577 | |
Not Available |
Full Name | Ms Kimberly A Donohue |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 6701 N Charles St, Baltimore, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265651343 | NPI | - | NPPES |
KJ4364798601 | Other | MD | CAREFIRST MARYLAND |
S1400031 | Other | MD | CAREFIRST REGIONAL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | R147480 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Kimberly A Donohue, CNM Po Box 631568, Baltimore, MD 21263-1568 Ph: () - | Ms Kimberly A Donohue, CNM 6701 N Charles St, Labor & Delivery, Baltimore, MD 21204-6808 Ph: (443) 849-2577 |
News Archive
In a pair of related studies, chemists from the Florida campus of The Scripps Research Institute (TSRI) have identified and designed dozens of molecular "warheads" that not only can detect a key biomarker of cancer, but also could be developed into a potent new class of drug candidates for a range of diseases.
The U.S. Food and Drug Administration today approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.
Malaria is still responsible for over a million deaths every year, even though it has been known for some years that sleeping under an insecticide-treated net (ITN) greatly reduces the chance of being bitten by the mosquitoes which carry the disease.
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has closed on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical Industries Limited, a top 20 pharmaceutical company, for the development of its novel anti-cancer compound, RX-3117. RX-3117 is a small molecule, new chemical entity (NCE), nucleoside compound that has an anti-metabolite mechanism of action, and has therapeutic potential in a broad range of cancers including colon, lung and pancreatic cancer.
A study published in the June issue of Anesthesiology has shown that a drug metabolite of the opioid morphine may be a key factor in the paradoxical increased sensitivity to pain caused by chronic morphine use. For the first time, this metabolite (called morphine-6 glucuronide, or M6G) was shown to act independently of the pain receptors typically targeted during morphine administration.
› Verified 6 days ago
Ms. Sharon Maree Elmes-curtis, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 6701 N Charles St, Dept Of Labor And Delivery, Baltimore, MD 21204 Phone: 443-849-2577 | |
Archana Sharma, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 301 Saint Paul Pl, Tower # 306, Baltimore, MD 21202 Phone: 410-385-5151 Fax: 410-962-8763 | |
Sarah Proett, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 900 S Caton Ave, Mailbox 081, Baltimore, MD 21229 Phone: 443-703-3200 Fax: 443-703-3201 | |
Ms. Lauren Kelly Rosales, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1701 Barclay St, Baltimore, MD 21202 Phone: 630-809-6115 | |
Julia Bluestone, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 330 N Howard St, Baltimore, MD 21201 Phone: 410-576-2130 | |
Anne B Woods, C.N.M. Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 9000 Franklin Square Dr, Women's Pavilion, Baltimore, MD 21237 Phone: 443-777-8005 | |
Mrs. Kara Hickey, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 330 N Howard St, Suite 200, Baltimore, MD 21201 Phone: 301-332-4968 |